Data / Medical devices / United States / BioFire Defense, LLC
BioFire Defense, LLC: FDA-registered device maker in Salt Lake City, UT, United States, 10 510(k) clearances
BioFire Defense, LLC is registered with the FDA (registration 3010770794) in Salt Lake City, UT, United States. It lists 17 device types. The FDA files 10 510(k) clearances under its listings, the newest dated March 12, 2025. 4 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3010770794
- Address
- 79 W 4500 S Ste 14, Salt Lake City, UT, United States, 84107
- Owner or operator
- BIOMERIEUX SA (8020790)
- Roles
- Contract manufacturer, Manufacturer, Repackager or relabeler
- First device listed
- February 18, 2015
- Registered through
- 2026
- Brand names listed
- BIOFIRE FILMARRAY TF Panel, BIOFIRE FILMARRAY Tropical Fever (TF) Panel, BIOFIRE FILMARRAY Tropical Fever Panel, BIOFIRE SHIELD Control Kit for the BioFire Global Fever Panel, BIOFIRE SHIELD Control Kit for the BioFire Global Fever Special Pathogens Panel, BIOFIRE SPOTFIRE Control Station, BIOFIRE SPOTFIRE Module, BIOFIRE SPOTFIRE Respiratory (R) Panel and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| March 12, 2025 | K243822 | BioFire Warrior Panel; BioFire Warrior Panel Control Kit | PRD | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| March 22, 2023 | K213362 | BioFire Global Fever Special Pathogens Panel; BIOFIRE SHIELD Control Kit for the BioFire Global Fever Special Pathogens Panel | QVR | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| February 3, 2023 | K213954 | BIOFIRE SPOTFIRE Respiratory (R) Panel | QOF | Substantially Equivalent | Biofire Diagnostics | accessdata.fda.gov |
| October 20, 2022 | K220870 | BioFire Global Fever Panel, BIOFIRE SHIELD Control Kit for the BioFire Global Fever Panel | QMV | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| July 25, 2022 | K221460 | BioFire COVID-19 Test 2 | QQX | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| November 1, 2021 | K211079 | BioFire COVID-19 Test 2 | QQX | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| November 20, 2020 | K202382 | FilmArray Global Fever Panel External Control Kit | PMN | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| November 20, 2020 | DEN200043 | FilmArray Global Fever Panel | QMV | Unknown | Biofire Defense, LLC | accessdata.fda.gov |
| June 22, 2017 | K170883 | FilmArray NGDS Warrior Panel | PRD | Substantially Equivalent | Biofire Defense, LLC | accessdata.fda.gov |
| January 30, 2015 | K143178 | FilmArray 2.0 System | NSU | Substantially Equivalent | Biofire Diagnostics, LLC | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| July 16, 2026 | 99459 | Class II | Ongoing | FilmArray NGDS Warrior Panel REF NGDS-ASY-0007 UDI-DI code: (01)00851458005136 The FilmArray NGDS Warrior Panel is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArr | Firm has identified mismatches between the outbreak strain and the reference strain used in the development of its qualitative, multiplexed, nucleic acid-based in vitro diagnostic panel test. | accessdata.fda.gov |
| July 10, 2025 | 97286 | Class II | Ongoing | FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system. | FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup. | accessdata.fda.gov |
| August 20, 2019 | 84887 | Class III | Terminated | FilmArray NGDS Warrior Panel, Ref: NGDS-ASY-0007, UDI: (01)00851458005136, IVD, Rx Only | The firm has identified that an incorrect instruction for use (IFU) revision was included in the qualitative, multiplexed, nucleic acid-based in vitro diagnostic test kit. | accessdata.fda.gov |
| August 13, 2014 | 69032 | Class III | Terminated | JBAIDS Instrument System Software version 3.5.0.72. The JBAIDS instrument is a portable thermocycler and real-time fluorimeter capable of simultaneous and rapid identification of multiple biological warfare and clinical | BioFire Defense, LLC is initiating a field action for JBAIDS Software version 3.5.0.72 because the wrong version software may have been installed. | accessdata.fda.gov |
Compare with other makers
- All makers of Reagents, 2019-Novel Coronavirus Nucleic Acid
- All makers of Respiratory Specimen Nucleic Acid Sars-Cov-2 Test
- All makers of Reagents, Ebola Zaire Virus (Detected In The West Africa Outbreak In 2014) Nucleic Acid
- All makers of Instrumentation For Clinical Multiplex Test Systems
- All makers of Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays
Updated August 4, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.